Conexeu Sciences Inc.

Conexeu Sciences Inc. (CNXU) went public through a direct listing on Nasdaq Capital Market on May 11, 2026, with a reference price of $2.00. McMillan advised the company.

Conexeu Sciences Inc. is an early-stage medical device company building collagen-based regenerative tissue products. It was formed to acquire and commercialize intellectual property developed at the University of British Columbia.

Status

Direct listing

Ticker

CNXU

Exchange

Nasdaq Capital Market

Listed

May 11, 2026

Price

$2.00

First filed

Nov 28, 2025

Company counsel

McMillan

Sector

Healthcare

Country / state

NV